ST THOMAS DEKALB HOSPITAL — History
CCN 440148 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$11M
Latest Revenue (FY2022)
-1.7%
Revenue CAGR (3yr)
-32.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $11M | $13M | $11M | -15.4% | -1.7% |
| Operating Expenses | $14M | $15M | $14M | -4.2% | +0.5% |
| Operating Margin | -26.6% | -16.9% | -32.3% | -91.6% | +0.0% |
| Net Income | $-3M | $-2M | $-3M | -62.0% | +0.0% |
| Licensed Beds | 18 | 18 | 18 | +0.0% | +0.0% |
| Total Patient Days | 1,381 | 1,723 | 1,676 | -2.7% | +10.2% |
| Medicare Day % | 29% | 25% | 23% | -9.0% | -11.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -3.3% ($11M → $11M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.7%
This Hospital
+7.6%
State Avg
Latest Margin
-32.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $11M | -35.2% |
| FY2024 (proj) | $10M | -38.0% |
| FY2025 (proj) | $10M | -40.9% |